DBD DIEBOLD NIXDORF, Inc
Calculating & Accounting Machines (No Electronic Computers) · NYSE · SEC CIK 28823 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.3%
TTM net income YoY51.6%
TTM EPS YoY56.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin25.0%
Operating margin5.4%
Net margin2.0%
FCF margin—
EBITDA margin7.3%
Returns
ROE7.5%
ROA2.1%
ROIC (approx.)8.1%
Asset turnover1.06x
Leverage & solvency
Liabilities / assets74.2%
Debt / equity1.01x
Current ratio1.27x
Interest coverage2.23x
Cash quality & payout
Operating cash flow / net income2.45x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.81B | $3.75B | $3.46B | $3.91B | $3.90B |
| Cost of revenue | $2.84B | $2.83B | $2.70B | $2.86B | $2.87B |
| Gross profit | $961.20M | $920.00M | $757.30M | $1.04B | $1.03B |
| R&D expense | $86.70M | $93.60M | $120.70M | $126.30M | $133.40M |
| SG&A expense | $632.50M | $643.60M | $741.60M | $775.60M | $858.60M |
| Operating income | $242.00M | $182.10M | -$211.70M | $137.10M | $24.00M |
| Interest expense | $85.70M | $155.30M | $199.20M | $195.30M | $266.80M |
| Pretax income | $125.10M | $47.30M | -$438.60M | -$50.70M | -$269.50M |
| Income tax | $24.10M | $64.30M | $149.20M | $27.70M | -$1.00M |
| Net income | $94.60M | -$16.50M | -$581.40M | -$78.80M | -$269.10M |
| EBITDA | $369.50M | $314.40M | -$155.30M | $208.00M | $97.70M |
| EPS (basic) | 2.57 | -0.44 | -7.36 | -1.01 | -3.47 |
| EPS (diluted) | 2.54 | -0.44 | -7.36 | -1.01 | -3.47 |
| Dividends declared per share | — | — | — | — | 0.00 |
| Weighted avg. shares (diluted) | 37.20M | 37.60M | 79.00M | 78.30M | 77.60M |
| Balance sheet | |||||
| Cash & equivalents | $387.30M | $311.30M | $319.10M | $388.90M | $324.50M |
| Short-term investments | $29.10M | $16.90M | $24.60M | $34.30M | $37.20M |
| Receivables | $609.40M | $588.50M | $612.20M | $595.20M | $646.90M |
| Inventory | $521.00M | $528.10M | $588.10M | $544.20M | $498.20M |
| Current assets | $1.79B | $1.67B | $1.77B | $1.89B | $1.86B |
| PP&E, net | — | $128.10M | $120.70M | $138.10M | $177.50M |
| Goodwill | $642.40M | $586.40M | $702.30M | $743.60M | $800.40M |
| Intangibles | $792.40M | $778.60M | $257.60M | $347.50M | $448.60M |
| Total assets | $3.85B | $3.54B | $3.06B | $3.51B | $3.66B |
| Current liabilities | $1.37B | $1.27B | $1.60B | $1.75B | $1.65B |
| Short-term debt | — | $200,000 | — | — | — |
| Long-term debt | $938.50M | $927.30M | $2.59B | $2.25B | $2.34B |
| Total debt | $938.50M | $927.50M | $2.59B | $2.25B | $2.34B |
| Total liabilities | $2.75B | $2.61B | $4.44B | $4.34B | $4.47B |
| Shareholders' equity | $1.10B | $929.80M | -$1.38B | -$845.10M | -$827.10M |
| Net debt | $551.20M | $616.20M | $2.27B | $1.86B | $2.01B |
| Shares outstanding | 35.38M | 37.58M | 79.10M | 78.35M | 77.68M |
| Cash flow statement | |||||
| Operating cash flow | $300.70M | $149.20M | -$387.90M | $123.30M | $18.00M |
| Investing cash flow | -$97.60M | -$45.50M | -$23.80M | -$49.20M | -$82.60M |
| Financing cash flow | -$143.90M | -$366.50M | $349.80M | -$3.60M | $16.90M |
| Depreciation & amortization | $127.50M | $132.30M | $56.40M | $70.90M | $73.70M |
| Stock-based compensation | $12.10M | $9.70M | $13.40M | $13.80M | $14.90M |
| Dividends paid | — | — | — | — | $0 |
| Share buybacks | $130.70M | $0 | $7.80M | $7.70M | $6.60M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.